DK117563B - Analogifremgangsmåde til fremstilling af 17α,21-(1'-alkyl-1'-alkoxy-methylendioxy)-11β-hydroxy-9-α-halogen-16β-methyl-1,4-pregnadien-3,20-dioner. - Google Patents

Analogifremgangsmåde til fremstilling af 17α,21-(1'-alkyl-1'-alkoxy-methylendioxy)-11β-hydroxy-9-α-halogen-16β-methyl-1,4-pregnadien-3,20-dioner.

Info

Publication number
DK117563B
DK117563B DK234564AA DK234564A DK117563B DK 117563 B DK117563 B DK 117563B DK 234564A A DK234564A A DK 234564AA DK 234564 A DK234564 A DK 234564A DK 117563 B DK117563 B DK 117563B
Authority
DK
Denmark
Prior art keywords
pregnadiene
diones
methylenedioxy
alkoxy
hydroxy
Prior art date
Application number
DK234564AA
Other languages
English (en)
Inventor
N Weir
J Elks
P May
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of DK117563B publication Critical patent/DK117563B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
DK234564AA 1963-05-10 1964-05-09 Analogifremgangsmåde til fremstilling af 17α,21-(1'-alkyl-1'-alkoxy-methylendioxy)-11β-hydroxy-9-α-halogen-16β-methyl-1,4-pregnadien-3,20-dioner. DK117563B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1864163 1963-05-10
GB362164 1964-01-28

Publications (1)

Publication Number Publication Date
DK117563B true DK117563B (da) 1970-05-11

Family

ID=26238480

Family Applications (1)

Application Number Title Priority Date Filing Date
DK234564AA DK117563B (da) 1963-05-10 1964-05-09 Analogifremgangsmåde til fremstilling af 17α,21-(1'-alkyl-1'-alkoxy-methylendioxy)-11β-hydroxy-9-α-halogen-16β-methyl-1,4-pregnadien-3,20-dioner.

Country Status (12)

Country Link
US (1) US3312591A (da)
BE (1) BE647709A (da)
BR (1) BR6459033D0 (da)
CH (1) CH435267A (da)
DE (1) DE1443955A1 (da)
DK (1) DK117563B (da)
ES (1) ES299652A1 (da)
FR (1) FR3821M (da)
GB (1) GB1043347A (da)
IT (1) IT1053251B (da)
NL (1) NL6405165A (da)
SE (1) SE317970B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3499081A (en) * 1966-12-21 1970-03-03 Squibb & Sons Inc 9-chloroprogestational agents
DE1668079B2 (de) * 1968-01-18 1976-09-16 Hoechst Ag, 6000 Frankfurt Dialkylorthocarbonate von 17alpha, 21-dihydroxysteroiden und verfahren zu ihrer herstellung
US3789121A (en) * 1971-11-26 1974-01-29 Warner Lambert Co 17{60 ,21-orthobutyrates of 6{60 , 9{60 -difluoro-hydrocortisone and 6{60 , 9{60 -difluoroprednisolone, compositions containing same and the use thereof as anti-inflammatory agents
GB1382614A (en) * 1972-01-10 1975-02-05 Squibb & Sons Inc Steroid compositions
US3892856A (en) * 1974-04-10 1975-07-01 Squibb & Sons Inc Topical steroid formulation
US4018918A (en) * 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
DE2645104C2 (de) * 1976-10-04 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
US4069322A (en) * 1976-10-12 1978-01-17 Interx Research Corporation Pro-drugs for the improved delivery of certain selected anti-inflammatory steroids
US4323564A (en) * 1977-04-28 1982-04-06 Syntex (U.S.A.) Inc. Esters of 6-chloro-11β, 17α,21-trihydroxypregna-1,4,6-triene-3,20-dione
JPS6040439B2 (ja) * 1978-03-29 1985-09-11 大正製薬株式会社 ヒドロコルチゾン誘導体
FR2510582B1 (fr) 1981-07-30 1986-05-30 Sipsy Steroides esterifies en la position 17 et thio-esterifies en la position 21, leur procede de preparation et leur application comme medicament
US4849211A (en) * 1988-03-16 1989-07-18 Schrauzer Gerhard N Product and method for the treatment of acne and other skin disorders

Also Published As

Publication number Publication date
CH435267A (de) 1967-05-15
BR6459033D0 (pt) 1973-08-09
SE317970B (da) 1969-12-01
FR3821M (fr) 1966-01-10
GB1043347A (en) 1966-09-21
IT1053251B (it) 1981-08-31
US3312591A (en) 1967-04-04
BE647709A (da) 1964-11-09
NL6405165A (da) 1964-11-11
DE1443955A1 (da) 1970-01-15
ES299652A1 (es) 1964-11-01

Similar Documents

Publication Publication Date Title
DK116205B (da) Analogifremgangsmåde til fremstilling af 17α-alkanoyloxy-9α-halogen-16β-methyl-11β,21-dihydroxy-Δ<1,4>-pregnadien-3,20-dioner.
DK129835B (da) Analogifremgangsmåde til fremstilling af 2-chlor-6α-fluor-16α-methyl-pregna-1,4-dien-3,20-dioner.
DK116870B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 11β,21-dihydroxy-3,20-dioxo- eller 21-hydroxy-3,11,20-trioxo-pregna-1,4-dien-(17α 16&alpha,-d)-2'metyloxazoliner eller 21-estere deraf.
DK117563B (da) Analogifremgangsmåde til fremstilling af 17α,21-(1'-alkyl-1'-alkoxy-methylendioxy)-11β-hydroxy-9-α-halogen-16β-methyl-1,4-pregnadien-3,20-dioner.
DK128352B (da) Analogifremgangsmåde til fremstilling af 9α-fluor-11β-hydroxypregna-1,4-dien-3,20-dion-[17α,16α-d]-oxazolidinoxaziner.
DK120190B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive 17-estere af 9α,11β-dihalogen-16α-alkyl-Δ<1,4>-pregnadien-17α,21-diol-3,20-dioner.
DK120337B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 3-keto-6-halogen-9β10α-Δ<4,6>-steroiddiener af androstan- eller pregnanrækken.
DK119764B (da) Fremgangsmåde til fremstilling af 3-spiro-3'-diaziridin- eller diazirinsteroider af androstan- eller estranrækken.
DK108281C (da) Fremgangsmåde til fremstilling af 17α,21-dihydroxy-steroider eller 21-estere deraf.
DK111141B (da) Fremgangsmåde til fremstilling af 2'-acetamido-2'-desoxyglucosider eller -galactosider af 17α,21-dihydroxy-11-oxygenerede -3,20-diketo-steroider af pregnanrækken.
DK114060B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 1,2β-metylensteroider af androstan- eller 9-norandrostanrækken.
DK126647B (da) Analogifremgangsmåde til fremstilling af 16α,17α-(substitueret-methylen)-steroider af pregnanrækken.
DK113920B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 21-(β-ethoxy-ethoxy)-acetater eller 21-(β-ethoxy-β-ethoxy-ethoxy)-acetater af steroider af pregnanrækken.
DK122452B (da) Analogifremgangsmåde til fremstilling af 21-estere af 6α-halogen-16α-methyl-Δ<1,4>-pregnadien-11β,21-diol-3,20-dioner.
DK124539B (da) Fremgangsmåde til fremstilling af 6-hydroxy-3-keto-Δ<1,4>-steroider af pregnan- eller androstanrækken.
DK118556B (da) Analogifremgangsmåde til fremstilling af 16α-methyl-9α-chlor-Δ<1,4>-pregnadien-11β,21-diol-3,20-dioner eller 21-estere deraf.
DK103018C (da) Fremgangsmåde til fremstilling af 3-keto-Δ<4,6>-steroider af androstan- eller pregnanrækken.
DK113639B (da) Analogifremgangsmåde til fremstilling af 9α-flour-11β-hydroxypregna-1,4-dien-[17α,16α-d]-oxazolin-3,20-dioner.
DK120746B (da) Analogifremgangsmåde til fremstilling af 4-klor-1,2α-metylen-Δ<4,6>-pregnadien-17α-ol-3,20-dion eller 17-estere deraf.
DK132121B (da) Fremgangsmåde til fremstilling af 17alfa-hydroxypregna-4,9(11)-dien-3,20-dion.
DK111615B (da) Fremgangsmåde til fremstilling af 6α,9α-difluor-16α-metyl-Δ<1,4>-pregnadien-11β,21-diol-3,20-dion eller estere deraf.
DK112380B (da) Fremgangsmåde til fremstilling af 6-methyl-3-oxo-Δ<4,7>-steroider af pregnanrækken.
DK112168B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 17-estere af 16α-halogen-6α-methyl-17α-hydroxy-4-pregnen-3,20-dioner.
DK105403C (da) Fremgangsmåde til fremstilling af 1'-substituerede 17α,21-(1'-alkoxy)-methylendioxysteroider.
DK101117C (da) Fremgangsmåde til fremstilling af Δ<3,5>-steroider af pregnan-, androstan- eller østranrækken.